Provided by Tiger Trade Technology Pte. Ltd.

HUTCHMED

21.700
-0.280-1.27%
Volume:8.11M
Turnover:172.60M
Market Cap:18.92B
PE:5.33
High:21.940
Open:21.940
Low:20.700
Close:21.980
52wk High:30.750
52wk Low:18.360
Shares:872.00M
HK Float Shares:872.00M
Volume Ratio:2.71
T/O Rate:0.93%
Dividend:- -
Dividend Rate:- -
EPS(LYR):4.074
ROE:45.25%
ROA:-1.62%
PB:1.95
PE(LYR):5.33
PS:4.40

Loading ...

Hutchmed Begins Blood Cancer Drug Trial

MT Newswires Live
·
Yesterday

HUTCHMED Initiates Phase III Trial in China for HMPL-760 in Relapsed/Refractory DLBCL

Stock News
·
Yesterday

HUTCHMED launches Phase III China trial of HMPL-760 plus R-GemOx in relapsed/refractory DLBCL

Reuters
·
Yesterday

HUTCHMED Initiates Phase Iii Trial of Hmpl-760 in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma in China

THOMSON REUTERS
·
Yesterday

HUTCHMED (China) Ltd. files initial beneficial ownership statement for Deputy CFO Lorenso Chiu

Reuters
·
Mar 19

HUTCHMED (China) Ltd. files Form 3 initial beneficial ownership statement for CEO and CSO Su Wei-guo

Reuters
·
Mar 16

HUTCHMED (00013) completes vesting of 19,913 LTIP shares to CEO Dr Weiguo Su

Bulletin Express
·
Mar 16

CICC Maintains Outperform Rating on HUTCHMED with HK$30 Target Price

Stock News
·
Mar 12

HUTCHMED (China) Ltd. Files Initial Beneficial Ownership Statement for Director and CFO Cheng Chig Fung

Reuters
·
Mar 11

HUTCHMED (00013.HK) Vests 0.73 Million LTIP Shares to CEO and CFO

Bulletin Express
·
Mar 11

HUTCHMED Faces Dual Setbacks: New Drug Withdrawn, Core Products Decline

Deep News
·
Mar 11

HUTCHMED (China) Is Maintained at Buy by B of A Securities

Dow Jones
·
Mar 11

When Annual Report Meets Drug Withdrawal: Can HUTCHMED (00013) Break Its 20 Billion Valuation Stalemate?

Stock News
·
Mar 10

Hua Yuan Securities Reiterates "Buy" on HUTCHMED (00013), Sees Promise in ATTC Pipeline

Stock News
·
Mar 10

BRIEF-Hutchmed (China) Says Ipsen Initiates Market Withdrawal And Recall Of Tazverik In China

Reuters
·
Mar 10

HUTCHMED Commences Tazverik® Withdrawal and Product Recall

Stock News
·
Mar 09

HUTCHMED (China) Ltd - ІPsen Has Informed HUTCHMED That It Is Voluntarily Withdrawing TazverІK in US

THOMSON REUTERS
·
Mar 09

HUTCHMED (China) Ltd - Ipsen Initiates Market Withdrawal and Recall of Tazverik in China

THOMSON REUTERS
·
Mar 09

HUTCHMED initiates TAZVERIK recall in China, Hong Kong and Macau

Reuters
·
Mar 09

HUTCHMED (China): Withdrawal Not Expected to Impact Financial Guidance

THOMSON REUTERS
·
Mar 09